3 ms·

Universal flu vaccine: mRNA-based candidate enters clinical trial

• jfengel 3y ago
  Interesting that this vaccine was developed by the NIH itself, rather than Moderna or Pfizer. Such a thing, if it works, would be hugely lucrative. Any idea who would manufacture it, and who would profit from it?
  • Trouble_007 3y ago
    'Cost to the economy of influenza (flu)' (2018) Economic burden of seasonal influenza in the United States : https://pubmed.ncbi.nlm.nih.gov/29801998/ https://pubmed.ncbi.nlm.nih.gov/29801998/
• deleted 3y ago
  [deleted]